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ABSTRACT
Objectives: There is limited evidence on the
effectiveness of weight management programmes
provided within routine healthcare and inconsistent use
of outcome measures. Our aim was to evaluate a large
National Health Service (NHS) weight management
service and report absolute and proportional weight
losses over 12 months.
Design: Prospective observational study.
Setting: Glasgow and Clyde Weight Management
Service (GCWMS), which provides care for residents
of NHS Greater Glasgow and Clyde area (population
1.2 million).
Participants: All patients who began GCWMS
between 1 October 2008 and 30 September 2009.
Interventions: Structured educational lifestyle
programme employing cognitive behavioural therapy,
600 kcal deficit diet, physical activity advice, lower
calorie diet and pharmacotherapy.
Primary and secondary outcomes measures:
Baseline observation carried forward (BOCF), last
observation carried forward (LOCF) and changes in
programme completers reported using outcomes of
absolute 5 kg and 5% weight losses and mean weight
changes at a variety of time points.
Results: 6505 referrals were made to GCWMS, 5637
were eligible, 3460 opted in and 1916 (34%) attended
a first session. 78 patients were excluded from our
analysis on 1838 patients. 72.9% of patients were
women, mean age of all patients at baseline was
49.1 years, 43.3% lived in highly socioeconomically
deprived areas and mean weights and body mass
indices at baseline were 118.1 kg and 43.3 kg/m2,
respectively. 26% lost ≥5 kg by the end of phase 1,
30% by the end of phase 2 and 28% by the end of
phase 3 (all LOCF). Weight loss was more successful
among men, particularly those ≤29 years old.
Conclusions: Routine NHS weight management
services may achieve moderate weight losses through a
comprehensive evidence-based dietary, activity and
behavioural approach including psychological care.
Weight losses should be reported using a range of
outcome measures so that the effectiveness of different
services can be compared.
INTRODUCTION
The prevalence of obesity, deﬁned as a body
mass index (BMI) of 30 kg/m2 or greater, has
increased steeply over the past three decades to
become a major public health concern.1–3
Obesity raises the risk of many serious diseases,
including coronary artery disease and cancers.4
In the UK, national guidelines recommend
multicomponent weight management pro-
grammes involving calorie deﬁcient diets, phys-
ical activity and behavioural components for
the management of patients who are either
overweight or obese.5 6 Despite these recom-
mendations, the provision of weight manage-
ment services across the UK remains patchy
and there is limited published evidence of the
effectiveness of such interventions outside of a
research setting within the National Health
Service (NHS).7–10
There is a variety of different methods used
when reporting weight management out-
comes, with no agreed standard methodology
for analysis or follow-up period, which makes
comparison between programmes compli-
cated. It is, therefore, difﬁcult for health
authorities to make an informed choice when
commissioning weight management services.
Some studies include self-reported weights11
even though these are likely to be signiﬁcantly
underestimated.12 Weight loss programmes
Strengths and limitations of this study
▪ Describes a large National Health Service (NHS)
programme for severe and complex obesity.
▪ Comprehensive reporting of outcomes using a
variety of measures to allow comparison with
other studies.
▪ Lack of some baseline clinical risk factor data.
▪ Course completion defined using a lower thresh-
old than some other studies.
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have variable lengths so that reported weight loss out-
comes may represent changes over a few weeks or over a
year. It is difﬁcult to infer if weight losses reported at
12 weeks will be sustained in the medium to long term.7–9
Attendance is often poor but there is no consensus on
whether outcomes should be reported only on pro-
gramme completers, on all those who start a programme
or carried-forward from the last observation. Programme
completion has variously been deﬁned as attendance at
greater than 80%, 83% or 50% of sessions and it might be
argued that because of the association between attendance
and successful weight loss, higher thresholds will selectively
identify patients with greater weight losses.7 9 13 There is
also lack of agreement on which outcomes to publish with
some studies reporting mean weight changes, propor-
tional weight loss or absolute weight loss.
Only a small number of UK-based weight management
programmes have published 12-month outcome data and
the majority of these have been within a study
setting.10 11 13 14 The Counterweight Programme is delivered
in primary care with training of primary care staff provided
by a specialist team (mean baseline BMI 37 kg/m2).13 The
Counterweight Programme report that 31% of patients
achieved ≥5% weight loss in those completing the pro-
gramme though this attenuates to just 13.9% when all
patients are included; however, as this was an audit rather
than a study, there were no resources available to obtain
measured or self-reported weights in those who dropped
out.13 The other published research is based on commercial
programmes with Jebb et al14 reporting 12-month weight loss
outcomes from a randomised trial of WeightWatchers group
sessions compared with general practitioner (GP) care
alone (mean baseline BMI 31 kg/m2), though this study
included patients outside the UK. A recent trial of primary-
care based interventions concluded that those provided by
the NHS were ineffective.11 The Lighten Up Study11 com-
pared random allocation to a number of weight manage-
ment providers including commercial, pharmacy and
primary care services; where direct measurement was
unavailable due to non-attendance, ﬁnal weight was sought
by self-report. The mean BMI in Lighten Up was 33.8 kg/
m2. Weight Watchers had 46% of patients achieving ≥5%
weight loss in Jebb et al14 and 31% in Jolly et al11 (the most
successful of all the programmes offered in that study) using
measured plus self-reported 12-month weights.
There is currently no UK-based programme reporting
1 year outcomes for those patients with higher BMIs and
complex comorbidities. Our aim was, therefore, to
report 1 year outcomes from the NHS Greater Glasgow
and Clyde Weight Management Service (GCWMS), an
integrated service across primary and secondary care for
patients with severe obesity and obesity-related
comorbidities, including a large number of patients
from areas of high socioeconomic deprivation. We previ-
ously presented the results of the ﬁrst phase of this pro-
gramme.15 We have reported percentage and absolute
weight losses using both last and baseline observations to
allow maximum comparison with other services.
METHODS
Setting
In NHS Greater Glasgow and Clyde (NHSGGC) area,
population 1.2 million, a multicomponent weight manage-
ment programme, the GCWMS, is available to patients
aged 18 years and over with complex obesity (deﬁned as
BMI of ≥30 kg/m2 with obesity-related comorbidities or
BMI of ≥35 kg/m2) referred by their GP or hospital
doctor. The service, which is integrated across primary and
secondary care but delivered in community-based sites,
aims to achieve a ≥5 kg weight loss. In the hierarchy of
interventions for the treatment of obesity in NHSGGC this
service sits above local authority, commercial and third-
sector services, on the pathway to bariatric surgery. The
GCWMS model was developed in 2004 and extended
throughout the Health Board area in 2008.
The intervention is a time-limited structured educa-
tional lifestyle programme employing cognitive behav-
ioural therapy techniques alongside a 600 kcal deﬁcit
diet and physical activity advice. Phase 1 of the interven-
tion includes nine 90 min sessions delivered fortnightly
over a 16-week period. On ﬁnishing phase 1 patients can
choose to enter phase 2, which consists of three 1-h ses-
sions delivered at monthly intervals and includes a range
of treatment options including further lifestyle advice,
prescribed low-calorie diet or pharmacotherapy (orli-
stat). At the end of phase 2, or directly from the end of
phase 1, dependent on patient choice, patients enter a
weight maintenance programme (phase 3) comprising
12 1 h sessions delivered at monthly intervals. Patients
who fail to achieve their target weight loss can choose to
repeat phase 2 once more and then enter the mainten-
ance programme or if they fail to lose 5 kg and have a
BMI >40 kg/m2, or BMI>35 kg/m2 with comorbidities,
can opt for bariatric surgery.
Definitions of completers and time points
Patients were considered to be ‘completers’ if they
attended about half of the sessions in any phase. Thus,
in phase 1, completers had attended four or more
appointments; in phase 2, they had attended two or
more appointments; and in phase 3, they had attended
six or more appointments. For the time-speciﬁc out-
comes, there was often not a clinic date on the exact
date or week corresponding to 3, 6 or 12 months so we
deﬁned these periods as follows. For 3 months, we
sought a weight at 84 days (12 weeks). If no weight was
available at that time point, we used a later weight up to
98 days after starting the programme, or if that was also
unavailable, a weight from 70 days onwards was used. For
6 months, we sought a weight at 182 days (26 weeks). If
no weight was available, we used a later weight up to
210 days, or, if unavailable, a weight on or after 154 days
was used. For 12 months, we sought a weight at 364 days,
and if none was available, we extended the range up to
422 days, and if no weight was available, we extended it
down to 308 or more days.
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The service is funded entirely by the NHSGGC Health
Board. In 2009, the service employed 37.5 whole time
equivalent staff including 1 service lead, 5 team leaders,
11.5 dieticians, 5.5 clinical psychologists, 1 psychology
assistant, 4.2 physiotherapists, 6.3 administrative staff and
3 technical support staff. In the year 2008/2009, staff
costs were estimated to be £1.25 million. Additional
resources required to deliver the intervention include
scales, magnetic ﬂip charts, laptops and projectors and
appropriately adapted seating, provided at an estimated
non-recurring set-up cost of £20 000. There are no
direct costs to patients entering the GCWMS; however,
patients are required to cover any transportation costs to
and from appointments.
Data and statistical methods
All referrals to the GCWMS from 1 October 2008 to
30 September 2009 were followed until they completed
or left the programme. Data were censored at 1
December 2011, so that full data were available on
patients who completed phase 3, which occurred
around 19 months after starting the programme. Weight
change from entry to the programme to the end of
phases 1–3 is described. For comparison with other pub-
lished studies, weight change from entry to the pro-
gramme to 3, 6 and 12 months is also described.
Primary analyses were carried out in all patients who
began treatment. Missing data occur when patients fail
to attend appointments or leave the programme early;
reasons for non-attendance are generally not known.
Where data were missing, the method of last observation
carried forward (LOCF) was preferred though baseline
observation carried forward (BOCF) is also reported. All
analyses were performed using the STATA Statistical
Software Package V.11.
Socioeconomic status
As individual, social, educational and economic informa-
tion were not available for patients, we used the Scottish
Index of Multiple Deprivation (SIMD)16 to infer socio-
economic status. This is a validated area-based measure
of socioeconomic circumstances that uses individuals’
postcode of residence. The SIMD does not measure indi-
viduals’ socioeconomic status but that of their area of resi-
dence. The SIMD ranks 6505 small geographical areas
(datazones) across Scotland, each containing approxi-
mately 750 people from most deprived (1) to least
deprived (6505). These have been further categorised
into quintiles where 1 is most deprived and 5 is least
deprived. The SIMD score is composed of information
on seven domains: (1) income and beneﬁts, (2) employ-
ment in working age population, (3) health and health-
care utilisation, (4) educational attainment, skills and
training, (5) access to services and transport, (6)
recorded crime rates and (7) housing quality and
overcrowding.
Ethics approval
Non-identiﬁable data were provided by GCWMS for the
purposes of evaluating a routine NHS service. The work
was, therefore, not considered to require ethics commit-
tee approval.
RESULTS
Over the 1-year period from October 2008 to September
2009, 6505 referrals were made to GCWMS, of whom
5637 were eligible for the service, based on BMI, age,
area of residence and comorbidities. Of the 5637 eli-
gible patients, 61% (3460) opted into the service, 58%
(3249) attended for assessment, 3 were deemed ineli-
gible at assessment because their BMI was lower than
30 kg/m2, 38% (2153) opted to enter phase 1 and 34%
(1916) attended phase 1 at least once. From the dataset
of 1916 patients, we excluded a further 4 whose initial
BMI was recorded as ≤30 kg/m2 and 74 who were direc-
ted to a specialised disordered eating group (where they
received different, specialised psychological interven-
tions that are qualitatively different from the main pro-
gramme), leaving a ﬁnal sample for analysis of 1838
patients. The majority of the 1838 patients were woman
(72.9%), the mean age was 49.1 years (SD 13.5) and
men were older than women (mean ages 51.9 (SD
11.96) and 48.1 (SD 13.86) years, respectively) (table 1).
Most of the patients were in the most deprived quintile
(43.3%) of the SIMD with only 12.2% in the least
deprived quintile. The mean initial weight at ﬁrst attend-
ance in phase 1 was 118.1 kg, range 52.6–244.8 kg. BMI
was also high; the mean BMI at ﬁrst attendance in phase
1 was 43.26 (43.34 in men and 43.23 in women). Nearly
two-thirds (63.1%) of patients had BMI of 40 kg/m2 or
greater (class III obesity).
The cumulative weight loss at the end of each phase is
outlined in table 2. Almost three-quarters (72%) of
patients who started GCWMS attended at least four ses-
sions, and of these ‘completers’, 36% had lost 5 kg or
more by the end of phase 1. Twenty-six per cent of
patients lost 5 kg or more when last weighed in phase 1
(LOCF) and this was similar when calculated on a
BOCF basis. By the end of phase 2, 30% of patients who
started GCWMS had lost 5 kg or more when they were
last weighed (LOCF). One-third of patients (639/1838)
who started GCWMS were deemed to have completed
phase 2, and among them, 55% had lost 5 kg or more.
The relatively low completion rate to the end of phase 2
(35%) explains the large difference between BOCF and
LOCF results. Relatively few patients attended up to the
end of phase 2 and the BOCF assumes that weights did
not change from baseline among the majority who did
not provide a ﬁnal weight. However, by using the last
available weight, the LOCF indicates that 11% of
patients who did not have a weight recorded by the end
of phase 2 were known to have lost at least 5 kg when
last seen. By the end of phase 3, 28% of patients who
started GCWMS had lost 5 kg or more when they were
Logue J, Allardice G, Gillies M, et al. BMJ Open 2014;4:e003747. doi:10.1136/bmjopen-2013-003747 3
Open Access
 group.bmj.com on January 17, 2014 - Published by bmjopen.bmj.comDownloaded from 
last weighed. In total, 11% of patients who started
GCWMS complete phase 3 (208/1838), and among
them, 58% had lost 5 kg or more. Table 2 also presents
weight losses of ≥5%. For over three-quarters of patients,
a 5% weight loss meant loss of >5 kg in weight; this
resulted in fewer patients achieving the proportionate
loss than the absolute loss.
Of the 1358 patients who did not lose at least 5 kg in phase
1, 461 (33.9% using LOCF) entered phase 2. Their mean
weight change in phase 2 was −0.65 (95% CI −0.9 to
−0.4) kg. Of the complement of 480 patients who lost at least
5 kg in phase 1, 339 (70.6%) progressed into phase 2. Their
mean weight change in phase 2 was −0.75 (−1.1 to −0.4) kg.
As phase 2 represents the second and last of the
weight-loss phases of GCWMS programme, we report
determinants of weight loss by age, sex, socioeconomic
circumstances, initial weight and initial BMI by the end
of this phase in table 3 using the LOCF method. Men
were generally more successful at losing the 5 kg target
weight (mean losses in men and women were 4.16 and
3.4 kg, respectively). Both men and women in all age
groups from 30 to 70 years had similar success rates of
about 30%. However, patients aged 29 or under had dif-
ferent outcomes. Young men had greater success and
young women had less success (52% men vs 22%
women under 30 years achieved 5 kg weight loss)
although numbers of young men were small (N=25).
Deprivation did not appear to affect the proportion
losing their target weight. There was no clear trend
between initial weight or BMI and successful weight loss,
although patients who were heaviest had the greatest
proportion of losing 5 kg or more (41% of men and
48% of women).
In order to allow comparison of the results of
GCWMS with other services that describe weight loss at
Table 2 Cumulative weight loss at end of each phase from first clinic visit in phase 1
N Per cent Mean change and 95% CI (kg) Lost ≥5 kg Lost ≥5%
Phase 1
Completers 1322 71.9 −4.02 (−4.3 to −3.8) 471 (36%) 377 (29%)
All cases
BOCF 1838 −2.89 (−3.1 to −2.7) 471 (26%) 377 (21%)
LOCF 1838 −3.06 (−3.3 to −2.9) 480 (26%) 381 (21%)
Phase 1+2
Completers 639 34.8 −6.38 (−6.9 to −5.8) 349 (55%) 313 (49%)
All cases
BOCF 1838 −2.22 (−2.5 to −2.0) 349 (19%) 313 (17%)
LOCF 1838 −3.6 (−3.9 to −3.4) 550 (30%) 468 (25%)
Phases 1+2+3*
Completers 208 11.3 −8.48 (−9.7 to −7.2) 121 (58%) 117 (56%)
All cases
BOCF 1838 −0.96 (−1.1 to −0.8) 121 (7%) 117 (6%)
LOCF 1838 −3.56 (−3.8 to −3.3) 509 (28%) 434 (24%)
Completers attended ≥4 sessions in phase 1, ≥2 sessions in phase 2 and ≥6 sessions in phase 3.
Duration of phases: phase 1, 16 weeks; phase 2, 3 months (may be repeated); phase 3, 12 months.
*Phase 3 completers must have completed phase 1, and phase 2 if they entered it.
BOCF, baseline observation carried forward; LOCF, last observation carried forward.
Table 1 Baseline characteristics of 1838 patients who
started phase 1 of Glasgow and Clyde Weight
Management Service between October 2008 and
September 2009
N Per cent
All 1838 100
Gender
Male 498 27.1
Female 1340 72.9
Age (years)
≤29 192 10.5
30–39 268 14.6
40–49 481 26.2
50–59 476 25.9
60–69 320 17.4
≥70 101 5.5
SIMD
Most deprived 796 43.3
2 342 18.6
3 245 13.3
4 224 12.2
Least deprived 225 12.2
Not known 6 0.3
Initial weight (kg)
50–74 12 0.7
75–99 395 21.5
100–124 813 44.2
125–149 464 25.2
≥150 154 8.4
Initial BMI (kg/m2)
30–34 131 7.1
35–39 546 29.7
40–49 872 47.4
≥50 289 15.7
BMI, body mass index; SIMD, Scottish Index of Multiple
Deprivation.
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Table 3 Subgroup analyses of weight loss at end of phase 2, using LOCF method
Male Female
N
Mean weight
change and
95% CI (kg)
Percentage
lost ≥5 kg
Percentage
lost ≥5% N
Mean weight
change and
95% CI (kg)
Percentage
lost ≥5 kg
Percentage
lost ≥5%
All 498 −4.16 (−4.7 to −3.6) 33 24 1340 −3.4 (−3.7 to −3.1) 29 26
≤29 years 25 −5.17 (−7.8 to −2.6) 52 24 167 −2.16 (−2.9 to −1.4) 22 20
30–39 years 58 −3.19 (−4.4 to −2.0) 31 16 210 −3.81 (−4.6 to −3.0) 32 27
40–49 years 122 −4.75 (−6.1 to −3.4) 32 26 359 −3.45 (−4.0 to −2.9) 30 25
50–59 years 152 −4.16 (−5.3 to −3.0) 34 26 324 −3.84 (−4.4 to −3.3) 31 28
60–69 years 119 −3.69 (−4.6 to −2.8) 30 24 201 −3.09 (−3.6 to −2.5) 25 23
≥70 years 22 −4.93 (−7.9 to −2.0) 27 23 79 −3.66 (−4.5 to −2.8) 30 38
1 (most
deprived)
204 −4.02 (−4.9 to −3.1) 32 22 592 −3.23 (−3.6 to −2.8) 28 24
2 79 −3.55 (−4.7 to −2.4) 32 22 263 −3.61 (−4.2 to −3.0) 32 30
3 65 −3.83 (−5.3 to −2.4) 32 25 180 −3.54 (−4.2 to −2.9) 33 29
4 63 −5.24 (−7.1 to −3.3) 37 29 161 −2.97 (−3.8 to −2.1) 22 21
5 (least
deprived)
83 −4.61 (−6.1 to −3.1) 34 28 142 −4.01 (−4.9 to −3.2) 30 28
Initial weight (kg)
75–99 24 −4.84 (−6.4 to −3.2) 38 46 383 −2.69 (−3.1 to −2.3) 21 25
100–124 188 −3.21 (−3.9 to −2.6) 27 21 625 −3.34 (−3.7 to −3.0) 28 25
125–149 192 −4.39 (−5.4 to −3.4) 34 24 272 −4.17 (−4.9 to −3.4) 36 26
≥150 94 −5.44 (−7.2 to −3.7) 41 26 60 −5.04 (−7.2 to −2.9) 48 38
Initial BMI (kg/m2)
30–34 40 −3.55 (−4.8 to −2.3) 30 32 91 −2.75 (−3.6 to −1.9) 21 25
35–39 136 −3.0 (−3.8 to −2.2) 24 18 410 −3.13 (−3.5 to −2.7) 26 27
40–49 242 −4.32 (−5.1 to −3.5) 35 25 630 −3.49 (−3.9 to −3.1) 29 25
≥50 80 −5.97 (−8.1 to −3.9) 43 29 209 −3.93 (−4.8 to −3.1) 38 28
BMI, body mass index; LOCF, last observation carried forward.
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ﬁxed time points, we calculated weight changes at 3, 6
and 12 months (table 4)—although these are not recog-
nised as end points by GCWMS. These roughly corres-
pond to the ends of phases 1 and 2 while phase 3
corresponds to a time point of between 18 and
24 months. GCWMS does not aim to achieve 5 kg weight
losses as early as 3 months, so the 6 and 12 months
results are most meaningful. At both 6 and 12 months
after starting at GCWMS, 28% of patients (LOCF) had
lost 5 kg or more of their initial weight. Of patients with
a weight measured at around 6 months, 50% had lost
5 kg or more and of those who had actual weights
recorded around 12 months, 54% lost 5 kg or more.
However, because only 21.7% had their weights
recorded at 12 months, it can only be said for certain
that 12% of all patients who began the programme had
deﬁnitely lost 5 kg or more at this time point.
DISCUSSION
NHS GCWMS achieved a 5 kg weight loss in 28% of parti-
cipants at 12 months when the LOCF analysis is used. This
equates to 24% of participants losing 5% of their body
weight, because the mean weight was greater than 100 kg
at baseline. When complete cases are considered, 54% of
participants achieved at least 5 kg weight loss at
12 months. Overall, men achieved greater weight loss than
did women. Those with very high initial weight (>150 kg)
also did well with 48% of women and 41% of men losing
5 kg or more (38% and 26%, respectively losing 5%).
Owing to methodological differences, comparisons with
other published data are difﬁcult. Data from commercial
weight management programmes show WeightWatchers to
be a successful intervention with between 31%11 and 51%7
of participants losing 5 kg or 5% of their body weight.8
However, these data were from randomised research studies
with mean BMIs under 38 kg/m2 compared with the
GCWMS mean of 43 kg/m2. There were also differences in
data collection, with the Lighten Up study using patient self-
report for ﬁnal weight, a method known to result in
under-reporting of weight.12 It is not known why some
patients drop out of weight management programmes,
although within GCWMS, patients are given a target weight
loss of 5 kg and then offered the option of longer term
support of up to 2 years. Participants can choose to leave
earlier than this with possible reasons ranging from lack of
success and weight regain to weight loss success and the
feeling they can ‘go it alone’ and no longer need the
service; this makes the issue of missing data very difﬁcult
and explains why we and other studies get large differences
in results when using baseline or LOCF. Our deﬁnition of
course completion was lower than some others have used
and given that attendance is directly related to weight loss, it
is likely that if we used a higher threshold for completion,
weight losses would have been greater in this group. It is dif-
ﬁcult to compare the ﬁnal opt-in proportion, 62%, with
that of other studies in which very different recruitment
methods are used, such as widespread postal invitations,
rather than the individual GP referrals from GCWMS.
Retention of patients in GCWMS appears to be lower than
that in some other studies but the aim of the service is not
to retain all patients to the end of phase 3 but rather to be
ﬂexible in allowing them to leave if they have succeeded in
losing their target weight.
Currently, the GCWMS is based around a target of achiev-
ing a 5 kg weight loss. However, given the higher BMI of
participants in this specialist service, 5 kg is only 4.2% of the
mean body weight, as opposed to the 5 kg and 5% being
interchangeable outcomes in a population whose mean
weight is closer to 100 kg. Given the higher initial BMI and
range of comorbidities in the GCWMS population, it could
be argued that higher weight loss targets should be set.
Bariatric surgery has shown health beneﬁts for larger
weight losses than those achieved by conventional weight
management programmes17 and there are new non-surgical
interventions such as drug treatments,18 19 which promote
weight losses greater than 5 kg as well as the recent rival of
the popularity of low-energy liquid diets, which have the
potential for larger weight loss and also to modify
obesity-related comorbidities.20 21
Table 4 Cumulative weight changes at specified time from first clinic visit for 1838 patients, October 2008 to September
2009
N Per cent Mean change and 95% CI (kg) Lost ≥5 kg Lost ≥5%
3 months
Complete cases 1167 63.5 −3.7 (−3.9 to −3.5) 369 (32%) 289 (25%)
BOCF 1838 −2.4 (−2.5 to −2.2) 369 (20%) 289 (16%)
LOCF 1838 −2.7 (−2.9 to −2.5) 399 (22%) 308 (17%)
6 months
Complete cases 701 38.1 −5.8 (−6.3 to −5.4) 347 (50%) 310 (44%)
BOCF 1838 −2.2 (−2.4 to −2.0) 347 (19%) 310 (17%)
LOCF 1838 −3.4 (−3.6 to −3.2) 515 (28%) 433 (24%)
12 months
Complete cases 399 21.7 −7.2 (−8.1 to −6.3) 214 (54%) 203 (51%)
BOCF 1838 −1.6 (−1.8 to −1.3) 214 (12%) 203 (11%)
LOCF 1838 −3.6 (−3.9 to −3.3) 612 (28%) 447 (24%)
BOCF, baseline observation carried forward; LOCF, last observation carried forward.
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The major strength of our results are that they come
from a very large NHS service speciﬁcally targeting severe
and complex obesity, an area of concern due to the health-
care costs of such patients.22 We have provided a compre-
hensive description of the outcomes using baseline and
LOCF as well as linking outcomes to the programme struc-
ture and time-based observations. While there are many
NHS weight management programmes across the UK, the
majority are poorly evaluated or not at all, making their
effectiveness difﬁcult to ascertain. This results in a lack of
evidence for the commissioning and decommissioning of
these services and does not help in building arguments for
investment in such services at a time of ﬁnancial constraint.
There is an urgent need to deﬁne consistent analytical
methods, including how missing data should be treated,
and acceptable ranges when describing time points.
The major weakness in our current work is the lack of
ancillary information such as baseline characteristics and
changes in clinical risk factors (eg, blood pressure, lipids
and glycaemic control) or change in medications. This is
due to the data being from a real-life NHS service rather
than a study population, but clearly data collection could
be improved for future evaluations. Where BMI-speciﬁc
weight changes have been reported elsewhere in the UK,
there is some evidence that patients with greater baseline
weights were more likely to lose weight7 although Ahern
reported a weight gain in patients with class III obesity
(BMI ≥40 kg/m2). Our deﬁnition of course completion
was lower than some others have used and given that
attendance is directly related to weight loss, it is likely that
if we used a higher threshold for completion, weight losses
would have been greater in this group.
In conclusion, this is the ﬁrst publication of 12-month
results of a large NHS weight management programme
speciﬁcally targeted at patients with severe obesity. We
have shown modest results in achieving some success
with a 5 kg or greater weight loss in 28% of our patients
at 1 year but it is hard to compare these results with that
from others programmes. There is an urgent need for
standardised data collection from weight management
programmes. Consideration needs to be given as to the
treatment target in severely obese patients and how best
to achieve this within NHS services.
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